Science
Mechanism of Action
SODIUM CYCLODEXTRIN BUTYLSULFONATE, known as Sulfobutylether-β-cyclodextrin (SBE-β-CD), operates through the formation of inclusion complexes. Its distinctive structure features a hydrophobic internal cavity that precisely encapsulates insoluble substances, significantly enhancing their apparent solubility and overall stability within formulations. This encapsulation protects active ingredients, such as antioxidants and UV filters, from degradation and oxidative stress. Furthermore, the sulfobutyl ether substituents improve electrostatic interactions, bolstering complex stability and optimizing active ingredient delivery by creating an in situ reservoir effect within topical applications, thereby modulating skin penetration.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 An in vitro human skin absorption study demonstrated that SBE7-beta-CD significantly reduced the epidermal concentration of the sunscreen agent butyl-methoxydibenzoylmethane (BM-DBM). The concentration dropped from 2.29% of the applied dose (when free) to 0.66% of the applied dose, effectively limiting its direct contact with viable skin tissues.
Transparency
Dusting Analysis
Current research data does not indicate that SODIUM CYCLODEXTRIN BUTYLSULFONATE is commonly associated with dusting issues or provide specific dusting thresholds.
The Formula
Formulation
Stability
SODIUM CYCLODEXTRIN BUTYLSULFONATE exhibits high water solubility. While no specific optimal pH range for its intrinsic stability is noted for skincare, its complexation ability is pH-dependent. Studies show improved active ingredient stability when complexed with SBE-β-CD at physiological pH 7.4, and it is frequently utilized in solutions ranging from pH 7.0 to 7.4. Generally, cyclodextrins can undergo enzymatic hydrolysis in acidic solutions. As a co-solvent and stabilizer, its inclusion complexes are reversible and competitive, necessitating careful consideration of other excipients or active ingredients.
Synergies
- Enhances the solubility of hydrophobic and poorly soluble active ingredients.
- Improves the stability and bioavailability of sensitive compounds like antioxidants and UV filters.
- Modulates and optimizes the skin delivery of active ingredients, potentially creating a reservoir effect.
Conflicts
- Competitive binding with other excipients or active ingredients can impede desired complex formation.
- Certain surfactants, such as sodium lauryl sulphate, may influence the dissolution rate and skin permeation of cyclodextrin-complexed drugs.
- Potential interactions with other polymers, like sodium hyaluronate, could lead to altered solution properties or crosslinking effects.
Safety
Safety Profile
Cyclodextrins, including SBE-β-CD, are generally considered to have a significant margin of safety across various skin applications, deemed suitable for topical products by the European Commission. The FDA has approved SBE-β-CD for use in over 14 pharmaceutical drugs, and natural cyclodextrins are recognized as Generally Recognized As Safe (GRAS). However, it is noted that high doses of cyclodextrins may exhibit active properties and potential adverse effects, suggesting careful dose-dependent consideration.
Your Skin
Skin Compatibility
Our Assessment
Verdict
SODIUM CYCLODEXTRIN BUTYLSULFONATE is a highly valuable ingredient for precision skincare, effectively enhancing the solubility, stability, and controlled delivery of active ingredients, and demonstrably reducing unwanted epidermal absorption of certain compounds, all while maintaining a favorable safety profile.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources